RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
ESMO OPEN
Collezione AO Cuneo

Items : 8

An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study. in ESMO open / ESMO Open. 2023 Aug;8(4):101598. doi: 10.1016/j.esmoop.2023.101598. Epub 2023 Jul 17.

2023
AO Cuneo
ASL Cuneo 2

Porta C; Rizzo M; Trerotoli P; Funaioli C; Ricotta R; Santoni M; Ortega C; Giron Berrios JR; Facchini G; Incorvaia L; Zanardi E; Stellato M; Fornarini G; Galli L; Atzori F; Passarelli A; Bersanelli M; Procopio G; Bracarda S; Caffo O; Rudà R; Maiorano BA; Massari F; Internò V;

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study. in ESMO open / ESMO Open. 2021 Apr;6(2):100064. doi: 10.1016/j.esmoop.2021.100064. Epub 2021 Mar 10.

2021
AO Cuneo

De Summa S; Tommasi S; Sava S; Minisini A; Brugnara S; Occelli M; Merelli B; Festino L; Di Giacomo AM; Cocorocchio E; Del Vecchio M; Ridolfi L; Queirolo P; Antonini Cappellini G; Chiaron Sileni V; Ramondetta A; Quaglino P; Maule M; Strippoli S; Guida M;

Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study. in ESMO open / ESMO Open. 2020 Oct;5(5):e000876. doi: 10.1136/esmoopen-2020-000876.

2020
AO Cuneo

Crosetto N; Falletta A; Lo Nigro C; De Angelis C; Vanella P; Geuna E; Abbona A; Vandone AM; Montemurro F; Michelotti A; Paccagnella M; Garrone O; Di Maio M; Merlano M;

How I treat squamous ENT cancer. in ESMO open / ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019.

2019
AO Cuneo

Merlano MC; Denaro N; Galizia D; Garrone O;

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? in ESMO open / ESMO Open. 2018 Jun 20;3(4):e000404. doi: 10.1136/esmoopen-2018-000404. eCollection 2018.

2018
AO Cuneo

Merlano MC; Garrone O;

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer. in ESMO open / ESMO Open. 2018 Jul 9;3(4):e000403. doi: 10.1136/esmoopen-2018-000403. eCollection 2018.

2018
AO Cuneo

Falcone A; Boni L; Cremolini C; Delliponti L; Vitello S; Antonuzzo L; Martinelli E; Vannini F; Marsico VA; Colombo C; Granetto C; Leone F; Passardi A; Boccaccino A; Pella N; Di Battista M; Martignetti A; Zaniboni A; Zucchelli G; Salvatore L; Rossini D; Marmorino F; Burgio V; Masi G; Pietrantonio F; Bonetti A; Antoniotti C; Lonardi S; Borelli B; et alii...

Heterogeneity of colon cancer: from bench to bedside. in ESMO open / ESMO Open. 2017 Aug 22;2(3):e000218. doi: 10.1136/esmoopen-2017-000218. eCollection 2017.

2017
AO Cuneo

Garrone O; Ricci V; Fea E; Merlano MC; Granetto C;

Immune-related response criteria: light and shadows. in ESMO open / ESMO Open. 2016 Jul 7;1(4):e000082. doi: 10.1136/esmoopen-2016-000082. eCollection 2016.

2016
AO Cuneo

Garrone O; Occelli M; Merlano M;